In view of limited evidence-based acute treatments for spontaneous vertigo in vestibular migraine, this real-world cohort study assessed the effectiveness of rimegepant for acute vestibular migraine-related vertigo and factors associated with treatment response.MethodsClinical data were retrospectively collected from 86 patients with documented vestibular migraine treated with rimegepant 75 mg orally disintegrating...
Audiologists and vestibular specialists managing vestibular migraine patients should be aware that rimegepant shows real-world effectiveness for acute spontaneous vertigo episodes, and certain clinical predictors may help identify the best candidates — consider coordinating with neurology for prescribing.
Vestibular migraine is among the most common causes of episodic vertigo and has limited acute treatment options; real-world evidence for rimegepant fills a meaningful evidence gap.
- 01Rimegepant demonstrated effectiveness for acute spontaneous vertigo attacks in vestibular migraine patients.
- 02Clinical predictors of response were identified, potentially allowing patient selection in practice.
- 03This is a real-world cohort study, not an RCT, which limits causal inference.
- 04Published in Cephalalgia (DOI 10.1177/03331024261463533).
- 05Vestibular migraine is a leading but under-treated cause of episodic vertigo in adults.
Rimegepant is effective for treating acute spontaneous vertigo in vestibular migraine patients.
studypartially supportedSpecific clinical features can predict which vestibular migraine patients respond best to rimegepant.
studypartially supported- PMID
- 42377393
- DOI
- 10.1177/03331024261463533.
- Journal
- Cephalalgia
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients with vestibular migraine experiencing acute spontaneous vertigo attacks
- Intervention
- Rimegepant for acute treatment of spontaneous vertigo in vestibular migraine
Primary outcomes
Effectiveness of rimegepant in reducing acute vertigo severity; Identification of clinical predictors of treatment response